These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38359700)

  • 1. Recent advances in intestinal fibrosis.
    Lenti MV; Santacroce G; Broglio G; Rossi CM; Di Sabatino A
    Mol Aspects Med; 2024 Apr; 96():101251. PubMed ID: 38359700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal fibrosis.
    Lenti MV; Di Sabatino A
    Mol Aspects Med; 2019 Feb; 65():100-109. PubMed ID: 30385174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of initiation and progression of intestinal fibrosis in IBD.
    Latella G; Di Gregorio J; Flati V; Rieder F; Lawrance IC
    Scand J Gastroenterol; 2015 Jan; 50(1):53-65. PubMed ID: 25523556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Bamias G; Pizarro TT; Cominelli F
    Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of myofibroblasts during the development of fibrosis in Crohn's disease.
    Li C; Kuemmerle JF
    J Dig Dis; 2020 Jun; 21(6):326-331. PubMed ID: 32092217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
    Truffi M; Sorrentino L; Monieri M; Fociani P; Mazzucchelli S; Bonzini M; Zerbi P; Sampietro GM; Di Sabatino A; Corsi F
    Inflamm Bowel Dis; 2018 Jan; 24(2):332-345. PubMed ID: 29361086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts.
    Johnson LA; Rodansky ES; Sauder KL; Horowitz JC; Mih JD; Tschumperlin DJ; Higgins PD
    Inflamm Bowel Dis; 2013 Apr; 19(5):891-903. PubMed ID: 23502354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease.
    Stallmach A; Schuppan D; Riese HH; Matthes H; Riecken EO
    Gastroenterology; 1992 Jun; 102(6):1920-9. PubMed ID: 1587410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
    Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.
    Hünerwadel A; Fagagnini S; Rogler G; Lutz C; Jaeger SU; Mamie C; Weder B; Ruiz PA; Hausmann M
    Sci Rep; 2018 Oct; 8(1):15182. PubMed ID: 30315190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease.
    Zorzi F; Calabrese E; Monteleone G
    Clin Sci (Lond); 2015 Dec; 129(12):1107-13. PubMed ID: 26494636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.
    Latella G; Viscido A
    Dig Dis Sci; 2020 May; 65(5):1299-1306. PubMed ID: 32124197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases in intestinal fibrosis.
    Biel C; Faber KN; Bank RA; Olinga P
    J Crohns Colitis; 2024 Mar; 18(3):462-478. PubMed ID: 37878770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin-11 Is a Regulator of Intestinal Fibrosis.
    Franzè E; Monteleone I; Laudisi F; Rizzo A; Dinallo V; Di Fusco D; Colantoni A; Ortenzi A; Giuffrida P; Di Carlo S; Sica GS; Di Sabatino A; Monteleone G
    J Crohns Colitis; 2020 Mar; 14(3):406-417. PubMed ID: 31504344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
    McKaig BC; McWilliams D; Watson SA; Mahida YR
    Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
    Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
    Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts.
    McKaig BC; Hughes K; Tighe PJ; Mahida YR
    Am J Physiol Cell Physiol; 2002 Jan; 282(1):C172-82. PubMed ID: 11742810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nr4A1 modulates inflammation-associated intestinal fibrosis and dampens fibrogenic signaling in myofibroblasts.
    Pulakazhi Venu VK; Alston L; Iftinca M; Tsai YC; Stephens M; Warriyar K V V; Rehal S; Hudson G; Szczepanski H; von der Weid PY; Altier C; Hirota SA
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(3):G280-G297. PubMed ID: 34288735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strictures in Crohn's Disease: From Pathophysiology to Treatment.
    Crespi M; Dulbecco P; De Ceglie A; Conio M
    Dig Dis Sci; 2020 Jul; 65(7):1904-1916. PubMed ID: 32279173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.